Cansortium Future Growth
Future criteria checks 1/6
Cansortium is forecast to grow revenue at 9.9% per annum. EPS is expected to grow by 115.9% per annum.
Key information
n/a
Earnings growth rate
115.9%
EPS growth rate
Pharmaceuticals earnings growth | 21.7% |
Revenue growth rate | 9.9% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 30 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 119 | N/A | 18 | 22 | 1 |
12/31/2024 | 106 | N/A | 7 | 15 | 1 |
3/31/2024 | 100 | -20 | 11 | 17 | N/A |
12/31/2023 | 97 | -23 | 12 | 18 | N/A |
9/30/2023 | 95 | -36 | 15 | 21 | N/A |
6/30/2023 | 92 | -36 | 12 | 19 | N/A |
3/31/2023 | 90 | -34 | 13 | 20 | N/A |
12/31/2022 | 88 | -37 | 12 | 19 | N/A |
9/30/2022 | 83 | -15 | 22 | 34 | N/A |
6/30/2022 | 76 | -2 | 7 | 24 | N/A |
3/31/2022 | 70 | -24 | -21 | 0 | N/A |
12/31/2021 | 65 | -19 | -26 | -5 | N/A |
9/30/2021 | 62 | -31 | -38 | -20 | N/A |
6/30/2021 | 61 | -47 | -26 | -15 | N/A |
3/31/2021 | 57 | -28 | -1 | 5 | N/A |
12/31/2020 | 52 | -37 | 1 | 7 | N/A |
9/30/2020 | 47 | -48 | 12 | 17 | N/A |
6/30/2020 | 40 | -51 | -5 | 2 | N/A |
3/31/2020 | 33 | -51 | -21 | -8 | N/A |
12/31/2019 | 29 | -53 | -37 | -23 | N/A |
9/30/2019 | 24 | -54 | -58 | -42 | N/A |
6/30/2019 | 19 | -13 | -46 | -29 | N/A |
3/31/2019 | 14 | -9 | -35 | -23 | N/A |
12/31/2018 | 8 | 0 | -22 | -12 | N/A |
9/30/2018 | 3 | 16 | -16 | -7 | N/A |
6/30/2018 | 0 | -15 | -13 | -8 | N/A |
3/31/2018 | 0 | -16 | -11 | -7 | N/A |
12/31/2017 | N/A | -10 | N/A | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 2WM's forecast earnings growth is above the savings rate (0.7%).
Earnings vs Market: Insufficient data to determine if 2WM's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if 2WM's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 2WM's revenue (9.9% per year) is forecast to grow faster than the German market (5.2% per year).
High Growth Revenue: 2WM's revenue (9.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2WM's Return on Equity is forecast to be high in 3 years time